CAR-T Manufacturing Validation Study with Pheresed Sample from cancer patients undergoing Leukapheresis for Stem cell Collection Autologous stem cell Transplant (COLLECT-2)
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2022 - 2025
Project Lead
Dr.Hari Menon
Authors
Dr.Hari Menon, Dr.Ganesha , Dr.Annie K Baa
Project Status
completed
Project Type
St John’s Medical College Research Society